Word

ELEVIAN

Status

Pending

Status Code

688

Status Date

Tuesday, December 12, 2023

Serial Number

97679967

Mark Type

4000

Filing Date

Wednesday, November 16, 2022

Published for Opposition

Tuesday, October 17, 2023

Trademark Owner History

Elevian, Inc. - Owner At Publication

Classifications

5 pharmaceutical preparations for the treatment and prevention of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes; transdermal drug delivery patches sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; implantable subcutaneous or intramuscular drug delivery devices sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; medical devices, namely, implantable or external pumps sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes for delivering drugs

44 pharmaceutical and medical diagnostic consultation services

10 drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; vacuum pumps for medical purposes; tubing for use with catheters; drug eluting coatings sold as an integral part of catheters

Trademark Events

Dec 12, 2023

Noa E-Mailed - Sou Required From Applicant

Oct 17, 2023

Official Gazette Publication Confirmation E-Mailed

Oct 17, 2023

Published For Opposition

Sep 27, 2023

Notification Of Notice Of Publication E-Mailed

Sep 13, 2023

Approved For Pub - Principal Register

Sep 13, 2023

Examiner's Amendment Entered

Sep 13, 2023

Notification Of Examiners Amendment E-Mailed

Sep 13, 2023

Examiners Amendment E-Mailed

Sep 13, 2023

Examiners Amendment -Written

Aug 29, 2023

Assigned To Examiner

Dec 7, 2022

New Application Office Supplied Data Entered

Nov 19, 2022

New Application Entered